MedTrace Logo

RESOLUTE China Registry:

NCT01243749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2018-04-05

No results posted yet for this study

Summary

To document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a real-world patient population requiring stent implantation.

Conditions

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Shubin Qiao, MD · Fu Wai Hospital, Beijing, China

  • Jiyan Chen, MD · Guangdong Provincial People's Hospital

  • Lianglong Chen, MD · Fujian Medical University Union Hospital

  • Shaoliang Chen, MD · The First Affiliated Hospital with Nanjing Medical University

  • Weimin Wang, MD · Peiking University People's Hospital

  • Guoying Zhu, MD · Wuhan Asia Heart Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2013-04-30
Completion
2017-12-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01243749 on ClinicalTrials.gov